Delek US (DK) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Voting matters and shareholder proposals
Election of ten directors is proposed, with all nominees recommended by the board for approval.
Advisory resolution to approve the executive compensation program for named executive officers is up for a vote.
Proposal to amend the 2016 Long-Term Incentive Plan to increase the number of shares available for issuance.
Ratification of Ernst & Young LLP as the independent registered public accounting firm for the 2025 fiscal year.
Board retains discretion to vote on any other matters that may arise during the meeting.
Board of directors and corporate governance
Ten director nominees are listed for election at the annual meeting.
Board recommends voting in favor of all director nominees.
Executive compensation and say-on-pay
Advisory vote on executive compensation program for named executive officers is included.
Amendment to the 2016 Long-Term Incentive Plan seeks to increase share availability.
Latest events from Delek US
- Board recommends voting for all proposals, highlighting governance, compensation, and ESG focus.DK
Proxy Filing10 Mar 2026 - Q4 2025 saw robust EBITDA and cash flow gains, driven by EOP and regulatory relief.DK
Q4 202527 Feb 2026 - Q2 net loss, record throughput, and asset sales to deliver $500M+ cash inflow.DK
Q2 20242 Feb 2026 - Q3 2024: $93M adjusted net loss, $70.6M EBITDA, record Logistics, major asset sales, strong liquidity.DK
Q3 202416 Jan 2026 - Q4 net loss of $414M, but logistics growth and cost actions set up stronger 2025 cash flow.DK
Q4 202423 Dec 2025 - Shareholders will vote on directors, executive pay, incentive plan amendment, and auditor ratification.DK
Proxy Filing1 Dec 2025 - Q2 2025: Net loss, higher adjusted EBITDA, EOP gains, and strong liquidity amid volatility.DK
Q2 202523 Nov 2025 - Q1 2025 net loss of $172.7M, but logistics growth and cash flow initiatives drive outlook.DK
Q1 202521 Nov 2025 - Q3 2025 delivered $434M adjusted net income and $760M EBITDA, fueled by SRE and margin gains.DK
Q3 20259 Nov 2025